# TSHA (Taysha Gene Therapies, Inc.) - SEC EDGAR Financial Statements

> Taysha Gene Therapies, Inc. reported $5.49M in revenue and a net loss of $156.0M for the trailing twelve months ended September 30, 2026 (up 17.3% year over year), with a -2935.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/TSHA
- Markdown: https://convexityos.com/fundamentals/TSHA.md
- SEC CIK: 0001806310
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:27 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001806310&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $5.49M | +17.3% YoY |
| Operating Income | TTM | -$161.0M | -2935.4% margin |
| Net Income | TTM | -$156.0M | -2844.6% net margin |
| Diluted EPS | TTM | -$0.38 | Split-adjusted |
| Free Cash Flow | TTM | -$141.7M | -2582.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $422.8M | Total debt: $54.59M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $9.77M | $8.33M | $15.45M | $2.50M | -- | -- |
| Research & Development | $86.40M | $66.00M | $56.78M | $91.17M | $131.9M | $31.89M |
| Total Operating Expenses | $120.3M | $99.79M | $87.89M | $164.9M | $173.3M | $43.00M |
| **Operating Income** | -$110.5M | -$91.46M | -$72.44M | -$162.4M | -$173.3M | -$43.00M |
| **EBITDA** | -$109.4M | -$90.21M | -$71.07M | -$161.3M | -$172.8M | -$42.99M |
| Interest Income | $9.22M | $6.94M | $3.57M | -- | -- | -- |
| Interest Expense | $63K | $102K | $5.00M | $3.80M | $1.43M | $28K |
| Income Tax Expense | $0 | $0 | $0 | $0 | -- | $0 |
| **Net Income** | -$109.0M | -$89.30M | -$111.6M | -$166.0M | -$174.5M | -$60.01M |
| Basic EPS | -$0.34 | -$0.36 | -$0.96 | -$3.78 | -$4.64 | -$3.40 |
| **Diluted EPS** | -$0.34 | -$0.36 | -$0.96 | -$3.78 | -$4.64 | -$3.40 |
| Basic Shares Outstanding | 319.7M | 250.1M | 116.1M | 44.0M | 37.7M | 17.7M |
| Diluted Shares Outstanding | 319.7M | 250.1M | 116.1M | 44.0M | 37.7M | 17.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $5.49M | $0 | $1.99M | $2.30M | $2.02M |
| Research & Development | $28.77M | $38.64M | $33.81M | $24.95M | $25.75M | $20.14M | $15.56M | $15.32M |
| Total Operating Expenses | $41.87M | $47.35M | $43.49M | $33.78M | $34.02M | $28.74M | $23.72M | $21.95M |
| **Operating Income** | -$41.87M | -$47.35M | -$43.49M | -$28.30M | -$34.02M | -$26.75M | -$21.42M | -$19.93M |
| **EBITDA** | -$41.67M | -$46.95M | -$43.19M | -$28.00M | -$33.82M | -$26.45M | -$21.14M | -$19.63M |
| Interest Income | $3.90M | $2.33M | $2.59M | $2.87M | $3.17M | $1.86M | $1.33M | $1.70M |
| Interest Expense | $4.0K | $6.0K | $9.0K | $12K | $15K | $17K | $19K | $22K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$39.13M | -$46.64M | -$42.41M | -$27.85M | -$32.73M | -$26.88M | -$21.53M | -$18.79M |
| Basic EPS | -$0.10 | -$0.13 | -$0.12 | -- | -$0.09 | -$0.09 | -$0.08 | -- |
| **Diluted EPS** | -$0.10 | -$0.13 | -$0.12 | -- | -$0.09 | -$0.09 | -$0.08 | -- |
| Basic Shares Outstanding | 406.1M | 369.0M | 366.6M | -- | 353.3M | 298.0M | 269.3M | -- |
| Diluted Shares Outstanding | 406.1M | 369.0M | 366.6M | -- | 353.3M | 298.0M | 269.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $319.8M | $139.0M | $143.9M | $87.88M | $149.1M | $251.3M | -- |
| **Cash & Short-Term Investments** | $319.8M | $139.0M | $143.9M | $87.88M | $149.1M | $251.3M | -- |
| Other Current Assets | $802K | $308K | $292K | $466K | $863K | $331K | -- |
| **Total Current Assets** | $324.6M | $142.1M | $149.9M | $96.42M | $159.6M | $257.9M | $15K |
| Property, Plant & Equipment, Net | $6.74M | $7.49M | $10.83M | $14.96M | $50.61M | $287K | -- |
| Other Non-Current Assets | $183K | $217K | $304K | $1.32M | $1.11M | -- | -- |
| **Total Non-Current Assets** | $18.67M | $18.23M | $22.86M | $29.86M | $54.35M | $1.00M | $0 |
| **Total Assets** | $343.3M | $160.4M | $172.7M | $126.3M | $214.0M | $258.9M | $15K |
| Accounts Payable | $6.28M | $3.59M | $6.37M | $10.95M | $21.76M | $1.99M | -- |
| Deferred Revenue (Current) | -- | $9.77M | $18.11M | $33.56M | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | $1.49M | $91K | $21K |
| **Total Current Liabilities** | $26.55M | $26.23M | $36.76M | $62.79M | $51.75M | $7.13M | $150K |
| Long-Term Debt | $50.11M | $43.94M | $40.51M | $37.97M | $37.19M | -- | -- |
| Other Non-Current Liabilities | $1.55M | $1.31M | $1.58M | $4.13M | $3.73M | $450K | -- |
| **Total Non-Current Liabilities** | $69.83M | $62.61M | $61.04M | $62.54M | $66.83M | $450K | $0 |
| **Total Liabilities** | $96.38M | $88.84M | $97.79M | $125.3M | $118.6M | $7.58M | $150K |
| **Total Debt (incl. Leases)** | $70.14M | $63.56M | $61.88M | $61.06M | $37.19M | -- | -- |
| Common Stock | $3.0K | $2.0K | $2.0K | $1.0K | -- | -- | -- |
| Retained Earnings | -$711.3M | -$602.3M | -$513.0M | -$401.4M | -$235.6M | -$61.13M | -$1.11M |
| Accumulated Other Comp. Income | -$192K | -$4.03M | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $246.9M | $71.53M | $74.94M | $949K | $95.38M | $251.3M | -$135K |
| Total Equity | $246.9M | $71.53M | $74.94M | $949K | $95.38M | $251.3M | -$135K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $422.8M | $455.4M | $276.6M | $319.8M | $297.3M | $312.8M | $116.6M | $139.0M |
| **Cash & Short-Term Investments** | $422.8M | $455.4M | $276.6M | $319.8M | $297.3M | $312.8M | $116.6M | $139.0M |
| Other Current Assets | $659K | $851K | $1.01M | $802K | $456K | $657K | $536K | $308K |
| **Total Current Assets** | $426.1M | $461.4M | $282.2M | $324.6M | $300.0M | $316.3M | $120.7M | $142.1M |
| Property, Plant & Equipment, Net | $2.53M | $2.41M | $6.45M | $6.74M | $6.80M | $6.96M | $7.24M | $7.49M |
| Other Non-Current Assets | $48K | $106K | $181K | $183K | $184K | $186K | $188K | $217K |
| **Total Non-Current Assets** | $8.97M | $9.00M | $18.10M | $18.67M | $16.60M | $17.07M | $17.65M | $18.23M |
| **Total Assets** | $435.0M | $470.4M | $300.4M | $343.3M | $316.6M | $333.3M | $138.4M | $160.4M |
| Accounts Payable | $5.59M | $9.16M | $4.56M | $6.28M | $5.44M | $7.71M | $4.33M | $3.59M |
| Deferred Revenue (Current) | -- | -- | -- | -- | $5.49M | $5.49M | $7.47M | $9.77M |
| **Total Current Liabilities** | $22.95M | $25.98M | $20.10M | $26.55M | $28.63M | $25.35M | $22.56M | $26.23M |
| Long-Term Debt | $47.33M | $49.26M | $48.96M | $50.11M | $50.85M | $41.05M | $42.45M | $43.94M |
| Other Non-Current Liabilities | $1.67M | $1.64M | $1.58M | $1.55M | $1.58M | $1.40M | $1.20M | $1.31M |
| **Total Non-Current Liabilities** | $55.11M | $57.19M | $68.31M | $69.83M | $68.93M | $59.26M | $60.75M | $62.61M |
| **Total Liabilities** | $78.06M | $83.17M | $88.41M | $96.38M | $97.56M | $84.60M | $83.30M | $88.84M |
| **Total Debt (incl. Leases)** | $54.59M | $56.71M | $68.55M | $70.14M | $69.08M | $59.76M | $61.63M | $63.56M |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K |
| Retained Earnings | -$839.5M | -$800.3M | -$753.7M | -$711.3M | -$683.4M | -$650.7M | -$623.8M | -$602.3M |
| Accumulated Other Comp. Income | $2.35M | $769K | $985K | -$192K | -$1.14M | -$699K | -$2.29M | -$4.03M |
| **Total Stockholders' Equity** | $357.0M | $387.3M | $211.9M | $246.9M | $219.0M | $248.7M | $55.06M | $71.53M |
| Total Equity | $357.0M | $387.3M | $211.9M | $246.9M | $219.0M | $248.7M | $55.06M | $71.53M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$109.0M | -$89.30M | -$111.6M | -$166.0M | -$174.5M | -$60.01M |
| Depreciation & Amortization | $1.15M | $1.25M | $1.37M | $1.17M | $492K | $9.0K |
| Stock-Based Compensation | $13.30M | $13.10M | $7.91M | $18.04M | $18.18M | $3.35M |
| Change in Payables | -$153K | -$2.92M | -$2.29M | -$7.80M | $14.49M | $1.96M |
| **Operating Cash Flow** | -$93.09M | -$81.22M | -$73.02M | -$88.39M | -$117.0M | -$30.73M |
| Capital Expenditure | -$738K | -$374K | -$3.87M | -$20.62M | -$15.30M | -$82K |
| **Free Cash Flow** | -$93.83M | -$81.60M | -$76.89M | -$109.0M | -$132.3M | -$30.81M |
| **Investing Cash Flow** | -$604K | -$363K | -$7.35M | -$24.93M | -$21.55M | -$9.08M |
| Common Stock Issued | -- | -- | $500K | -- | -- | -- |
| **Financing Cash Flow** | $274.6M | $76.68M | $136.4M | $52.10M | $39.08M | $291.1M |
| **Net Change in Cash** | $180.9M | -$4.90M | $56.02M | -$61.22M | -$99.51M | $251.3M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$39.13M | -$46.64M | -$42.41M | -$27.85M | -$32.73M | -$26.88M | -$21.53M | -$18.79M |
| Depreciation & Amortization | $200K | $400K | $295K | $299K | $200K | $300K | $283K | $304K |
| Stock-Based Compensation | $6.08M | $5.81M | $5.55M | $3.53M | $3.29M | $3.19M | $3.29M | $3.22M |
| Change in Payables | -$3.56M | $4.56M | $1.29M | -$2.13M | -$1.95M | $3.00M | $923K | -$1.50M |
| **Operating Cash Flow** | -$32.91M | -$40.42M | -$40.88M | -$26.72M | -$24.17M | -$20.18M | -$22.02M | -$18.31M |
| Capital Expenditure | -$443K | $1.0K | -$24K | -$250K | -$108K | -$2.0K | -$378K | $2.0K |
| **Free Cash Flow** | -$33.36M | -$40.42M | -$40.90M | -$26.97M | -$24.27M | -$20.18M | -$22.40M | -$18.31M |
| **Investing Cash Flow** | -$443K | $1.0K | -$3.02M | -$247K | -$48K | $62K | -$371K | $13K |
| **Financing Cash Flow** | $785K | $216.7M | $711K | $49.56M | $8.80M | $216.3M | -$52K | -$357K |
| **Net Change in Cash** | -$32.57M | $176.2M | -$43.19M | $22.59M | -$15.42M | $196.2M | -$22.44M | -$18.65M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1130.6% | -1097.6% | -468.8% | -6492.7% | -- | -- |
| **Net Profit Margin** | -1115.3% | -1071.6% | -722.1% | -6635.3% | -- | -- |
| Return on Equity (ROE) | -44.1% | -124.8% | -148.9% | -17493.6% | -183.0% | -23.9% |
| Return on Assets (ROA) | -31.7% | -55.7% | -64.6% | -131.5% | -81.6% | -23.2% |
| Current Ratio | 12.23x | 5.42x | 4.08x | 1.54x | 3.08x | 36.17x |
| Quick Ratio | 12.04x | 5.30x | 3.92x | 1.40x | 2.88x | 35.24x |
| Debt to Equity | 0.28x | 0.89x | 0.83x | 64.34x | 0.39x | -- |
| **Revenue Growth (YoY)** | +17.3% | -46.1% | +517.5% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -2935.4% | -2792.3% | -1774.4% | -1130.6% | -1618.5% | -1160.8% | -1225.8% | -1097.6% |
| **Net Profit Margin** | -2844.6% | -2728.0% | -1738.4% | -1115.3% | -1583.7% | -1145.0% | -1201.1% | -1071.6% |
| Return on Equity (ROE) | -43.7% | -38.6% | -61.3% | -44.1% | -45.6% | -37.3% | -157.6% | -124.8% |
| Return on Assets (ROA) | -35.9% | -31.8% | -43.2% | -31.7% | -31.6% | -27.8% | -62.7% | -55.7% |
| Current Ratio | 18.56x | 17.76x | 14.04x | 12.23x | 10.48x | 12.48x | 5.35x | 5.42x |
| Quick Ratio | 18.42x | 17.53x | 13.76x | 12.04x | 10.39x | 12.34x | 5.17x | 5.30x |
| Debt to Equity | 0.15x | 0.15x | 0.32x | 0.28x | 0.32x | 0.24x | 1.12x | 0.89x |
| **Revenue Growth (YoY)** | -- | -100.0% | -100.0% | +171.3% | -100.0% | +78.6% | -32.5% | -43.9% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -139.3% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
